Carisma Therapeutics
CARM
CARM
50 hedge funds and large institutions have $26.6M invested in Carisma Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 11 closing their positions.
Holders
50
Holders Change
-8
Holders Change %
-13.79%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
18
Reduced
13
Closed
11
Calls
$1.59M
Puts
$479K
Net Calls
+$1.11M
Net Calls Change
-$557K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$483K |
2 |
2
BlackRock
New York
|
$5.47M |
3 |
BCM
3
Bridgeway Capital Management
Houston,
Texas
|
$911K |
4 |
4
Northern Trust
Chicago,
Illinois
|
$700K |
5 |
5
Barclays
London,
United Kingdom
|
$107K |